ANEBULO PHARMACEUTICALS, INC. Earnings Per Share (Basic)
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Earnings Per Share (Basic) of -$0.05 per share for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-02-12
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.05.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.05.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-03-31 was -$0.04.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2024-12-31 was -$0.09.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$0.25.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$0.32.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$0.47, a 262.07% decline from fiscal 2022.
- ANEBULO PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was $0.29.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$0.05 10-Q · filed 2026-02-12 | -$0.10 10-Q · filed 2026-02-12 | |||
| 2025-09-30 | -$0.05 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | -$0.25 10-K · filed 2025-09-29 | ||||
| 2025-03-31 | -$0.04 10-Q · filed 2025-05-13 | -$0.20 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | -$0.09 10-Q · filed 2026-02-12 | -$0.17 10-Q · filed 2026-02-12 | |||
| 2024-09-30 | -$0.08 10-Q · filed 2025-11-13 | ||||
| 2024-06-30 | -$0.32 10-K · filed 2025-09-29 | ||||
| 2024-03-31 | -$0.06 10-Q · filed 2025-05-13 | -$0.27 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$0.11 10-Q · filed 2025-02-14 | -$0.20 10-Q · filed 2025-02-14 | |||
| 2023-09-30 | -$0.10 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | -$0.47 10-K · filed 2024-09-25 | $0.47 10-K · filed 2023-09-22 | |||
| 2023-03-31 | -$0.11 10-Q · filed 2024-05-15 | -$0.37 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$0.15 10-Q · filed 2024-02-13 | -$0.26 10-Q · filed 2024-02-13 | |||
| 2022-09-30 | -$0.11 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | -$0.10 derived: net income ÷ weighted average shares · filed 2023-09-22 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-09-22 | $0.29 10-K · filed 2023-09-22 | -$0.29 10-K · filed 2022-09-09 | |
| 2022-03-31 | -$0.08 10-Q · filed 2023-05-11 | -$0.19 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$0.05 10-Q · filed 2023-02-10 | -$0.11 10-Q · filed 2023-02-10 | |||
| 2021-09-30 | -$0.07 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | -$2.83 10-K · filed 2022-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |